Status: current, Defined. Date: 30-Nov 2018. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3150071000168112 | Methoblastin PFS (methotrexate 20 mg / 0.8 mL) injection, 1 x 0.8 mL syringe (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3150081000168110 | Methoblastin PFS 20 mg/0.8 mL injection, 0.8 mL syringe | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Methoblastin PFS 20 mg/0.8 mL injection, 0.8 mL syringe | Is a | methotrexate 20 mg/0.8 mL injection, 0.8 mL syringe | true | Inferred relationship | Some | ||
| Methoblastin PFS 20 mg/0.8 mL injection, 0.8 mL syringe | Is a | trade product pack | true | Inferred relationship | Some | ||
| Methoblastin PFS 20 mg/0.8 mL injection, 0.8 mL syringe | has TPUU | Methoblastin PFS 20 mg/0.8 mL injection, 0.8 mL syringe | true | Inferred relationship | Some | 1 | |
| Methoblastin PFS 20 mg/0.8 mL injection, 0.8 mL syringe | has TP | Methoblastin PFS | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Methoblastin PFS 20 mg/0.8 mL injection, 0.8 mL syringe | Is a | True | Methoblastin PFS 20 mg/0.8 mL injection, 0.8 mL syringe | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR